Ticker Details
Axogen, Inc. Common Stock AxoGen Inc is a medical technology company dedicated to peripheral nerve repair. It provide products and education to improve surgical treatment algorithms for peripheral nerve injuries.
IPO Date:	January 1, 1987
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$2.6B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.39 | 2.76%
Avg Daily Range (30 D):	$1.17 | 2.50%
Avg Daily Range (90 D):	$1.07 | 2.44%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.8M
Avg Daily Volume (90 D):	.91M

Trade Size
Avg Trade Size (Sh.):	83
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	55

Institutional Trades
Total Institutional Trades:	1,808
Avg Institutional Trade:	$1.79M
Avg Institutional Trade (30 D):	$3.13M
Avg Institutional Trade (90 D):	$3.2M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.19M
Avg Closing Trade (30 D):	$5.6M
Avg Closing Trade (90 D):	$6.43M
Avg Closing Volume:	92.18K

News

Feb 17, 2026 @ 12:00 PM Axogen, Inc. to Participate in Multiple Upcoming I... Source: Na

Feb 10, 2026 @ 12:00 PM Axogen, Inc. to Report Fourth Quarter and Full Yea... Source: Na

Jan 22, 2026 @ 4:18 AM Axogen Announces Pricing of Upsized $124 Million P... Source: Na

Jan 12, 2026 @ 12:00 PM Axogen, Inc. Reports Preliminary Unaudited Revenue... Source: Na

Dec 4, 2025 @ 1:01 AM Axogen Announces FDA Approval of Biologics License... Source: Axogen, Inc.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.66	$-.03	$-.38
Diluted EPS	$-.67	$-.03	$-.38
Revenue	$251.17M	$69.73M	$61.46M
Gross Profit	$187.27M	$50.67M	$46.19M
Net Income / Loss	$-33.55M	$-1.52M	$-19.58M
Operating Income / Loss	$-12.85M	$-2.16M	$-2.83M
Cost of Revenue	$63.91M	$19.06M	$15.27M
Net Cash Flow	$70.54M	$11.92M	$45.11M
PE Ratio